[27-21-pm] Science for Drug Formulation 5, Drug delivery system in therapy

2:58 PM - 3:10 PM JST(5:58 AM - 6:10 AM UTC)

[27-21-pm10S] Development of ASO/LNP formulations targeting TP53 intron retention

○Katsunori SAITO¹, Akihide YOSHIMI², Tomohiro ASAI¹ (1. Grad. Sch. Parm. Sci., Univ. of Shizuoka., 2. National Cancer Center Japan)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.